Leah M Cook
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Cancer Metastasis and ImmunologyGoogle:
"Leah Cook"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rajgopal S, Nakano K, Cook LM. (2023) Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy. Cancer Medicine |
| Alsamraae M, Costanzo-Garvey D, Teply BA, et al. (2023) Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression. Cancer Letters. 216468 |
| Johnson CS, Cook LM. (2023) Osteoid cell-derived chemokines drive bone-metastatic prostate cancer. Frontiers in Oncology. 13: 1100585 |
| Bhat AM, Mohapatra BC, Luan H, et al. (2023) Role of GD2 and its biosynthetic enzyme GD3 synthase in prostate cancer tumorigenesis. Biorxiv : the Preprint Server For Biology |
| Costanzo-Garvey DL, Case AJ, Watson GF, et al. (2022) Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils. Clinical & Experimental Metastasis |
| Alsamraae M, Cook LM. (2021) Emerging roles for myeloid immune cells in bone metastasis. Cancer Metastasis Reviews |
| McGuire JJ, Frieling JS, Lo CH, et al. (2021) Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nature Communications. 12: 723 |
| Costanzo-Garvey DL, Keeley T, Case AJ, et al. (2020) Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunology, Immunotherapy : Cii |
| Keeley T, Costanzo-Garvey DL, Cook LM. (2019) Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer. Trends in Cancer. 5: 789-798 |
| Cook LM, Frieling JS, Nerlakanti N, et al. (2019) Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene |